High prevalence of constipation and reduced quality of life in opioid-dependent patients treated with opioid substitution treatments

References

• European Drug Report 2015. Trends and developments. Lisbon: EMCDDA; Jun 2015. Available from: http://www.emcdda.europa.eu/.
   Google Scholar
• Compton WM, Jones CM, Baldwin GT. Relationship between nonmedical prescription-opioid use and heroin use. N Engl J Med. 2016;374:154–163.
   PubMed Web of Science ®Google Scholar
• Quaglio G, Lugoboni F, Pattaro C, et al. Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment. Drug Alcohol Depend. 2008;94:12–18.
   PubMed Web of Science ®Google Scholar
• Quaglio G, Pattaro C, Gerra G, et al. Buprenorphine in maintenance treatment: experience among Italian physicians in drug addiction centers. Am J Addict. 2010;19:222–230.
   PubMed Web of Science ®Google Scholar
• D’Aunno T, Pollack HA, Frimpong JA, et al. Evidence-based treatment for opioid disorders: a 23-year national study of methadone dose levels. J Subst Abuse Treat. 2014;47:245–250.
   PubMed Web of Science ®Google Scholar
• Coyne KS, Margolis MK, Yeomans K, et al. Opioid-induced constipation among patients with chronic noncancer pain in the United States, Canada, Germany, and the United Kingdom: laxative use, response, and symptom burden over time. Pain Med. 2015;16:1551–1565.
   PubMed Web of Science ®Google Scholar
• Webster LR. Opioid-induced constipation. Pain Med. 2015;16(Suppl 1):S16–S21.
   Google Scholar
• Argoff CE, Brennan MJ, Camilleri M, et al. Consensus recommendations on initiating prescription therapies for opioid-induced constipation. Pain Med. 2015;16:2324–2337.
   PubMed Web of Science ®Google Scholar
• Dorn S, Lembo A, Cremonini F. Opioid-induced bowel dysfunction: epidemiology, pathophysiology, diagnosis, and initial therapeutic approach. Am J Gastroenterol. 2014;2:31–37.
   PubMedGoogle Scholar
• Camilleri M, Drossman DA, Becker G, et al. Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation. Neurogastroenterol Motil. 2014;26:1386–1395.
   PubMed Web of Science ®Google Scholar
• Nelson AD, Camilleri M. Opioid-induced constipation: advances and clinical guidance. Ther Adv Chronic Dis. 2016;7:121–134.
   PubMed Web of Science ®Google Scholar
• Johnson DA, Argoff CE. Hot topics in primary care: management of opioid-induced constipation. J Fam Pract. 2015;64:S4–S9.
   Google Scholar
• De Maeyer J, Vanderplasschen W, Broekaert E. Quality of Life among opiate-dependent individuals: A review of literature. Int J Drug Policy. 2010;21:364–380.
   PubMed Web of Science ®Google Scholar
• Domingo-Salvany A, Brugal MT, Barrio G, et al. Gender differences in health related quality of life of young heroin users. Health Qual Life Outcomes. 2010;8:145.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders 4th ed. (text revision). Washington (DC): American Psychiatric Press; 2000.
   Google Scholar
• Agachan F, Chen T, Pfeifer J, et al. A constipation scoring system to simplify evaluation and management of constipated patients. Dis Colon Rectum. 1996;39:681–685.
   PubMed Web of Science ®Google Scholar
• Goldberg DP, Hillier VF. A scaled version of the General Health Questionnaire. Psychol Med. 1979;9:139–145.
   PubMed Web of Science ®Google Scholar
• Olesen AE, Drewes AM. Validated tools for evaluating opioid-induced bowel dysfunction. Adv Ther. 2011;28:279–294.
   PubMed Web of Science ®Google Scholar
• Bove A, Pucciani F, Bellini M, et al. Consensus statement AIGO/SICCR: diagnosis and treatment of chronic constipation and obstructed defecation (part I: diagnosis). World J Gastroenterol. 2012;18:1555–1564.
   PubMed Web of Science ®Google Scholar
• Bove A, D’Addetta V, Palone G, et al. Symptoms of obstructive defecation syndrome: functional outcome after stapled haemorrhoidectomy. Ann Ital Chir. 2015;86. pii: S0003469X15024550. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Dodi G, Lucio P, Spella M, et al. La raccolta dati nel paziente pelvi-perineologico – Evoluzione della cartella clinica informatica e del sistema IPGH. Pelvi-Perin RICP. 2006;25:19–27.
   Google Scholar
• Lugoboni F, Mirijello A, Faccini M, et al. Quality of life in a cohort of high-dose benzodiazepine dependent patients. Drug Alcohol Depend. 2014;142:105–109.
   PubMed Web of Science ®Google Scholar
• Montazeri A, Harirchi A, Shariati M, et al. The 12-item General Health Questionnaire (GHQ-12): translation and validation study of the Iranian version. Health Qual Life Outcomes. 2003;1:66–69.
   PubMedGoogle Scholar
• Jacob KS, Bhugra D, Mann AH. The validation of the 12-item General Health Questionnaire among ethnic Indian women living in the United Kingdom. Psychol Med. 1997;27:1215–1217.
   PubMed Web of Science ®Google Scholar
• Piccinelli M, Bisoffi G, Bon MG, et al. Validity and test-retest reliability of the Italian version of the 12-item General Health Questionnaire in general practice: a comparison between three scoring methods. Compr Psychiatry. 1993;34:198–205.
   PubMed Web of Science ®Google Scholar
• Politi PL, Piccinelli M, Wilkinson G. Reliability, validity and factor structure of the 12-item General Health Questionnaire among young males in Italy. Acta Psychiatr Scand. 1994;90:432–437.
   PubMed Web of Science ®Google Scholar
• Banks MH. Validation of the General Health Questionnaire in a young community sample. Psychol Med. 1983;13:349–353.
   PubMed Web of Science ®Google Scholar
• Cornelius BL, Groothoff JW, van der Klink JJ, et al. The performance of the K10, K6 and GHQ-12 to screen for present state DSM-IV disorders among disability claimants. BMC Public Health. 2013;13:128.
   PubMed Web of Science ®Google Scholar
• R Core Team. 2015. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. Available from: http://www.R-project.org/.
   Google Scholar
• Kreek MJ. Medical safety and side effects of methadone in tolerant individuals. JAMA. 1973;223:665–668.
   PubMed Web of Science ®Google Scholar
• Langrod J, Lowinson J, Ruiz P. Methadone treatment and physical complaints: a clinical analysis. Int J Addict. 1981;16:947–952.
   PubMed Web of Science ®Google Scholar
• Winstock AR, Lea T, Sheridan J. Patients’ help-seeking behaviours for health problems associated with methadone and buprenorphine treatment. Drug Alcohol Rev. 2008;27:393–397.
   PubMed Web of Science ®Google Scholar
• Sheridan J, Wheeler A, Walters C. Health problems and help-seeking activities of methadone maintenance clients at Auckland Methadone Service (AMS): potential for community pharmacy service expansion? Harm Reduct J. 2005;2:25.
   Google Scholar
• Magnelli F, Biondi L, Calabria R, et al. Safety and efficacy of buprenorphine/naloxone in opioid-dependent patients: an Italian observational study. Clin Drug Investig. 2010;30(Suppl 1):21–26.
   PubMed Web of Science ®Google Scholar
• Jamal MM, Adams AB, Jansen JP, et al. A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain. Am J Gastroenterol. 2015;110:725–732.
   PubMed Web of Science ®Google Scholar
• Mattick RP, Ali R, White JM, et al. Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients. Addiction. 2003;98:441–452.
   PubMed Web of Science ®Google Scholar
• Lofwall MR, Stitzer ML, Bigelow GE, et al. Comparative safety and side effect profiles of buprenorphine and methadone in the outpatient treatment of opioid dependence. Addict Disord Their Treat. 2005;4:49–64.
   Google Scholar
• Choung RS, Rey E, Richard Locke G 3rd, et al. Chronic constipation and co-morbidities: a prospective population-based nested case-control study. United Eur Gastroenterol J. 2016;4:142–151.
   PubMed Web of Science ®Google Scholar
• Shin A. Patient considerations in the management of chronic constipation: focus on prucalopride. Patient Prefer Adherence. 2016 Jul 28;10:1373–1384.
   PubMed Web of Science ®Google Scholar
• Pajusco B, Chiamulera C, Quaglio G, et al. Tobacco addiction and smoking status in heroin addicts under methadone vs. buprenorphine therapy. Int J Environ Res Public Health. 2012;9:932–942.
   PubMed Web of Science ®Google Scholar
• Addolorato G, Mirijello A, D’Angelo C, et al. State and trait anxiety and depression in patients affected by gastrointestinal diseases: psychometric evaluation of 1641 patients referred to an internal medicine outpatient setting. Int J Clin Pract. 2008;62:1063–1069.
   PubMed Web of Science ®Google Scholar
• Simonds VM, Whiffen VE. Are gender differences in depression explained by gender differences in co-morbid anxiety? J Affect Disord. 2003;77:197–202.
   PubMed Web of Science ®Google Scholar
• Amick HR, Gartlehner G, Gaynes BN, et al. Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis. BMJ. 2015;351:h6019.
   PubMed Web of Science ®Google Scholar